- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 14:06 | Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications | 166 | SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to... ► Artikel lesen | ||
| 14:05 | Investor AB: Bengt Thorsson appointed interim CEO of Piab Group | 123 | Piab Group announces that CEO, Peter Laurin, will step down from his role following a mutual agreement with the Board of Directors. The Board has appointed Bengt Thorsson, previous CEO of Permobil,... ► Artikel lesen | ||
| 13:58 | KommuneKredit announces Annual Report 2025 | 105 | Today, 9 March 2026, KommuneKredit has published its Annual
Report
2025.
Summary
Profit before value adjustments and tax came to DKK 507 million, down by DKK 16 million on the year-earlier... ► Artikel lesen | ||
| 13:48 | Mink Ventures Corporation: Mink Ventures Completes Drilling at Montcalm Ni Cu Co Project | 84 | TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- Mink Ventures Corporation (TSXV:MINK) ("Mink" or the "Company") today announced that it has completed a single, vertical drill hole (549 meters) at its... ► Artikel lesen | ||
| 13:48 | Genius Group Limited: Genius Group announces 2025 Financial Results with 80% Pro Forma Revenue Growth to $13.6 Million | 253 | Company completes transformation into a triple-engine AI education group preparing the World for the future of work: Genius School, Genius Academy and Genius Resorts SINGAPORE, March 09, 2026 (GLOBE... ► Artikel lesen | ||
| 13:48 | Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors | 65 | Inform future clinical development plans, further establishing elraglusib as a potential backbone therapy in difficult-to-treat cancersMechanisms of action support enhanced activity of GSK-3- plus... ► Artikel lesen | ||
| 13:46 | Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio (pegunigalsidase alfa) | 223 | Approved dosing regimen reduces the burden for eligible patients, their families, and the broader healthcare system by extending infusion interval from every-two-weeks to every-four-weeks for those... ► Artikel lesen | ||
| 13:46 | The Metals Company: NOAA Determines TMC USA's Consolidated Deep-Seabed Mining Application is in Substantial Compliance | 461 | Determination of substantial compliance marks a key step in the U.S. regulatory process for exploration and commercial recovery of polymetallic nodules in the Clarion Clipperton ZoneTMC USA's consolidated... ► Artikel lesen | ||
| 13:36 | Jet.AI Inc. Reports Full Year 2025 Financial Results | 82 | LAS VEGAS, March 09, 2026 (GLOBE NEWSWIRE) -- Jet.AI Inc. ("Jet.AI" or the "Company") (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced... ► Artikel lesen | ||
| 13:36 | YY Group Announces Preliminary Fiscal Year 2025 Financial Highlights | 79 | Singapore, March 09, 2026 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and integrated facilities management... ► Artikel lesen | ||
| 13:36 | Powell Max Limited Successfully Repositions for Its Next Phase of Growth | 68 | Hong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) ("Powell Max" or the "Company"), a financial communications services provider, is pleased to provide the following... ► Artikel lesen | ||
| 13:36 | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | 230 | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | ||
| 13:36 | DENTSPLY SIRONA Inc.: First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics | 137 | Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system - MAGNETOM Free.Max Dental Edition - has received FDA clearance in the United... ► Artikel lesen | ||
| 13:25 | Gubra A/S: AbbVie reports Positive Phase 1 Multiple Ascending Dose Results for ABBV-295, a Long-Acting Amylin Analog | 345 | Gubra's partner AbbVie today announced positive topline results from the 12 and 13-weeks Phase 1 Multiple Ascending Dose (MAD) trial showing that ABBV-295 was well tolerated with a dose-dependent significant... ► Artikel lesen | ||
| 13:24 | Safe Harbor Financial Services, Inc.: Safe Harbor Financial CEO Highlights Growth Platform Launch, Debt Elimination, and Financial Stabilization in Letter to Shareholders | 316 | DENVER, March 09, 2026 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor Financial ("Safe Harbor" or the "Company") (NASDAQ: SHFS), a leading fintech platform serving the banking, lending... ► Artikel lesen | ||
| 13:12 | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease | 458 | Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally... ► Artikel lesen | ||
| 13:12 | Adeia Inc.: Adeia Enters into Multi-Year IP License Agreement with AMD | 202 | SAN JOSE, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor... ► Artikel lesen | ||
| 13:10 | Signify share repurchase periodic update | 155 | Press Release
March 09, 2026
Signify share repurchase periodic update
Eindhoven, The Netherlands -
Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has... ► Artikel lesen | ||
| 13:10 | Acronis, Inc.: Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology | 255 | The latest report showcases Acronis' ongoing commitment to responsible business practices, sustainable growth, and protecting the digital worldSCHAFFHAUSEN, Switzerland, March 09, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | ||
| 13:06 | MBX Biosciences, Inc.: MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism | 94 | CARMEL, Ind., March 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel... ► Artikel lesen | ||
| 13:06 | Terra Innovatum Global N.V.: Terra Innovatum Secures Nuclear-Grade Graphite Order with Mersen, Advancing SOLO FOAK Deployment and Commercialization Readiness | 107 | Secures critical nuclear-grade graphite required for SOLO First-of-a-Kind (FOAK) reactor deployment targeted for 2027 and NOAK commercialization in 2028Initiates procurement following completion of... ► Artikel lesen | ||
| 13:06 | The Beauty Health Company: BeautyHealth Expands Skin Health Ecosystem with Growing Adoption of SkinStylus Nano-Channeling, a Popular Pairing with Hydrafacial Treatments | 103 | LONG BEACH, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the expansion of its professional skin health ecosystem... ► Artikel lesen | ||
| 13:06 | Galecto, Inc.: Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders | 100 | -- Company will trade on Nasdaq under trading symbol "DMRA" effective March 10, 2026 -- -- On track to submit IND or CTA for DMR-001 in mutant-calreticulin essential thrombocythemia and myelofibrosis... ► Artikel lesen | ||
| 13:06 | LB Pharmaceuticals Inc: LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors | 391 | NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia... ► Artikel lesen | ||
| 13:06 | Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Andrew S. Mikulski as Independent Director and Provides Patent Portfolio Update for Texatron Fusion Platform | 107 | SOUTHLAKE, Texas, March 09, 2026 (GLOBE NEWSWIRE) -- Renewal Fuels, Inc. (OTC: RNWF) ("RNWF", "American Fusion" or the "Company"), today announced the appointment of Andrew S. Mikulski as an independent... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.